Breaking News on Global Pharmaceutical Technology & Manufacturing

Drug Delivery: Top Headlines

BMS pays $125m to Promedior in second 'right-to-buy' option in fibrosis space

BMS enters an agreement for the option to buy Promedior

01-Sep-2015 - Bristol-Myers Squibb has acquired the rights to buy immunotherapy firm Promedior and could pay up to $1.25bn (€1.1bn) depending on the clinical development of its lead fibrosis product PRM-151.

Related news

News in brief

Scientists build ‘microfish’ robots for controlled drug delivery

27-Aug-2015 - US researchers say 3-D printed microscopic fish robots will allow intelligent drug delivery.

Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone

27-Aug-2015 - Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.

Device advice: Intertek study shows its key to consider devices in formulation development

26-Aug-2015 - Pharma firms developing inhalable drugs often fail to test that their formulations are compatible with their intended delivery devices early enough according to Intertek.

Google launches life sci unit as standalone Alphabet company

24-Aug-2015 - Google has announced plans to launch its life sciences team as a standalone unit under its new Alphabet structure.

Unilife whistleblower case blows over; Ex-exec apologises

20-Aug-2015 - An erstwhile whistleblower who accused Unilife of fraud and violating US FDA validation regulations has apologised and withdrawn his allegations.

European firms form JV for protein delivery polymers

11-Aug-2015 - French firm MedinCell and Dutch company Corbion have formed a JV to produce polymers for unusual drug delivery of large and small molecule drugs.

FDA approves first 3D-printed drug

04-Aug-2015 - A private Pennsylvania company says it has made the first 3D-printed drug to be approved by the US FDA.

Drug Delivery: Featured news

Key Industry Events


Access all events listing

Our events, Shows & Conferences...